Table 1.

Effect of SMe1EC2 on endothelaemia, on basal chemiluminiscence and on NO_x and GSH levels in the aorta after 5 weeks of diabetes.

Group	Endothelaemia	CL	NOx	GSH
C	2.29 ± 0.29	0.573±0.13	108.82±11.21	4.34±0.70
D	3.71 ± 0.25*	1.153±0.18 *	61.90±14.42*	1.70±0.66*
D – SMe1EC2	2.05 ± 0.51+	0.925±0.12	89.85±5.02	2.78±0.62

C – control group, D – diabetic group, D-SMe1EC2 – diabetic rats treateted with SMe1EC2. Endothelaemia is expressed in the cell number/10µl blood, chemiluminiscence (CL) as AUC (area under the curve) in mV/min/mg aortic tissue, NOx levels in nmol/mg protein, levels of reduced glutathione (GSH) in µg/mg protein. Results are means ± S.E.M., n=5–9,* p<0.05 versus control. ⁺ p<0.05 versus diabetes